These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6779284)

  • 21. Tablet splitting: is it worthwhile? Analysis of drug content and weight uniformity for half tablets of 16 commonly used medications in the outpatient setting.
    Helmy SA
    J Manag Care Spec Pharm; 2015 Jan; 21(1):76-86. PubMed ID: 25562775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Technologic control of tablet coatings].
    Dia S; Guyot JC; Traisnel M
    J Pharm Belg; 1973; 28(6):663-80. PubMed ID: 4774837
    [No Abstract]   [Full Text] [Related]  

  • 23. On-line content uniformity determination of tablets using low-resolution Raman spectroscopy.
    Wikström H; Romero-Torres S; Wongweragiat S; Williams JA; Grant ER; Taylor LS
    Appl Spectrosc; 2006 Jun; 60(6):672-81. PubMed ID: 16808869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The presence of microorganisms in some common excipients used in tablet formulation.
    Obuekwe IF; Eichie F
    Acta Pol Pharm; 2006; 63(2):121-5. PubMed ID: 17514875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Terahertz pulsed imaging and near infrared imaging to monitor the coating process of pharmaceutical tablets.
    Maurer L; Leuenberger H
    Int J Pharm; 2009 Mar; 370(1-2):8-16. PubMed ID: 19084585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measuring the distribution of density and tabletting force in pharmaceutical tablets by chemical imaging.
    Ellison CD; Ennis BJ; Hamad ML; Lyon RC
    J Pharm Biomed Anal; 2008 Sep; 48(1):1-7. PubMed ID: 18539424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of on-line Raman spectroscopy for characterizing relationships between drug hydration state and tablet physical stability.
    Hausman DS; Cambron RT; Sakr A
    Int J Pharm; 2005 Aug; 299(1-2):19-33. PubMed ID: 15979262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimation of mean potency and content uniformity of tablets: a new approach.
    Comer JP; Breunig HL; Broadlick DE; Sampson CB
    J Pharm Sci; 1970 Feb; 59(2):210-4. PubMed ID: 5411343
    [No Abstract]   [Full Text] [Related]  

  • 29. Formulation and evaluation of dried yeast tablets using different techniques.
    Al-Mohizea AM; Ahmed MO; Al-jenoobi FI; Mahrous GM; Abdel-Rahman AA
    Eur J Pharm Biopharm; 2007 Aug; 67(1):253-9. PubMed ID: 17270410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tablet identification using near-infrared spectroscopy (NIRS) for pharmaceutical quality control.
    Alvarenga L; Ferreira D; Altekruse D; Menezes JC; Lochmann D
    J Pharm Biomed Anal; 2008 Sep; 48(1):62-9. PubMed ID: 18572342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of content and uniformity of content of tablets prepared with a low concentration in active ingredient.
    Gayot A; Blouet E; Leterme P; Traisnel M
    Boll Chim Farm; 1988; 127(9-10):218-20. PubMed ID: 3248160
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of marketed and formulated furosemide tablets.
    Elgindy NA; Ismail AA; Gadalla MA
    Pharmazie; 1981 Sep; 36(9):628-30. PubMed ID: 7301904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of a market surveillance study in The Netherlands on break-mark tablets.
    Barends DM; Groot DW; van der Steen JC; de Kaste D; Frijlink HW
    Pharmeur Sci Notes; 2006 Dec; 2006(2):1-7. PubMed ID: 17691208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The development of a blend-sampling technique to assess the uniformity of a powder mixture.
    Garcia TP; Wilkinson SJ; Scott JF
    Drug Dev Ind Pharm; 2001 Apr; 27(4):297-307. PubMed ID: 11411897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Applications of NIR in early stage formulation development. Part I. Semi-quantitative blend uniformity and content uniformity analyses by reflectance NIR without calibration models.
    Li W; Bashai-Woldu A; Ballard J; Johnson M; Agresta M; Rasmussen H; Hu S; Cunningham J; Winstead D
    Int J Pharm; 2007 Aug; 340(1-2):97-103. PubMed ID: 17467204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of the SeDeM Diagram and a new mathematical equation in the design of direct compression tablet formulation.
    Suñé-Negre JM; Pérez-Lozano P; Miñarro M; Roig M; Fuster R; Hernández C; Ruhí R; García-Montoya E; Ticó JR
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1029-39. PubMed ID: 18367387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Content uniformity testing: suitability of different approaches for marketed low dose tablets.
    Abdel Hamid MM; Elnabrawi MA; Alanazi FK; Mohamed MI; Sakr AA
    Pharm Dev Technol; 2013; 18(6):1277-87. PubMed ID: 22324336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The construction and uses of factorial designs in the preparation of solid dosage forms. Part 1: Effervescent acetylsalicylic acid tablets.
    El-Banna HM; Minina SA
    Pharmazie; 1981 Jun; 36(6):417-20. PubMed ID: 7279987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of a fully automated method for the chromatographic determination of content uniformity of drug tablets.
    Toro I; Dulsat JF; Fábregas JL; Claramunt J
    J Pharm Biomed Anal; 2004 Sep; 36(1):57-63. PubMed ID: 15351048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Active ingredient release from solid drug forms--test methods, evaluation, influencing parameters].
    Knop K
    Pharm Unserer Zeit; 1999 Nov; 28(6):301-8. PubMed ID: 10614132
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.